Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
7.28B
Market cap7.28B
Price-Earnings ratio
9.69
Price-Earnings ratio9.69
Dividend yield
Dividend yield
Average volume
283.37K
Average volume283.37K
High today
$275.61
High today$275.61
Low today
$267.55
Low today$267.55
Open price
$275.61
Open price$275.61
Volume
243.69K
Volume243.69K
52 Week high
$343.12
52 Week high$343.12
52 Week low
$211.43
52 Week low$211.43

Stock Snapshot

The current Bio-Rad Laboratories Class A(BIO) stock price is $269.77, with a market capitalization of 7.28B. The stock trades at a price-to-earnings (P/E) ratio of 9.69.

On 2026-03-08, Bio-Rad Laboratories Class A(BIO) stock moved within a range of $267.55 to $275.61. With shares now at $269.77, the stock is trading +0.8% above its intraday low and -2.1% below the session's peak.

Trading activity shows a volume of 243.69K, compared to an average daily volume of 283.37K.

The stock's 52-week range extends from a low of $211.43 to a high of $343.12.

The stock's 52-week range extends from a low of $211.43 to a high of $343.12.

BIO News

Simply Wall St 4d
Assessing Bio-Rad Valuation After Mixed Share Price Performance And Recurring Revenue Shift

Bio-Rad Laboratories (BIO) has been drawing attention after a mixed stretch for the share price, with gains over the past year but declines over the past 3 mont...

Assessing Bio-Rad Valuation After Mixed Share Price Performance And Recurring Revenue Shift

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.